A prospective trial of midwest breast cancer patients: a p53 gene mutation is the most important predictor of adverse outcome (Q54058828)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q67440680)
(P304) 32-38
(P407) (Q1860)
(P433) 1
(P478) 89
(P577) Saturday, January 1, 2000
(P1433) (Q332492)
(P1476) "A prospective trial of midwest breast cancer patients: a p53 gene mutation is the most important predictor of adverse outcome" (language: en)
(P2093) H Blaszyk
A Hartmann
D Schaid
L E Wold
J S Kovach
S S Sommer
(P2860) (Q35976693)
(Q27851503)
(Q43552305)
(Q53350484)
(Q36135944)
(Q34400583)
(Q41331238)
(Q33538455)
(Q25938997)
(Q54189041)
(Q37730372)
(Q50802481)
(Q29615610)
(Q29615031)
(Q54172779)
(Q52862568)
(Q45887109)
(Q71169983)
(Q71563602)
(Q71019316)
(Q71191754)
(Q71198612)
(Q72839445)
(Q77683176)
(Q68170270)
(Q71019320)
(Q71082995)
(Q74013133)
other details